1. Home
  2. Labeler Index
  3. Northwind Pharmaceuticals, Llc
  4. 51655-243
  5. Product Images: Valsartan And Hydrochlorothiazide

Product Images Valsartan And Hydrochlorothiazide

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Valsartan And Hydrochlorothiazide NDC 51655-243 by Northwind Pharmaceuticals, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label - 51655 243 52

Label - 51655 243 52

NDC 51655-243-52 is for a drug called Valsartan and Hydrochlorothiazide, which is available in the form of tablets. Each film-coated tablet contains USP 320mg of Valsartan and USP 25mg of Hydrochlorothiazide. The package contains 30 tablets and it is Rx only, meaning it requires a prescription to purchase. The dosage and storage instructions can be found in the package insert. The tablets should be stored in the original container at a temperature between 20° - 25°C (68° - 77°F) and should be protected from moisture and heat. The drug should be kept out of the reach of children. The tablets have been repackaged by Northwind Pharmaceuticals from the original product labeled as 0378-6325-XX manufactured by Mylan Pharmaceuticals Inc. The GTIN code for this drug is 0351655243527, and the provided LOT number is 0000000000. The expiration date mentioned is 00/00/0000, which implies that this information is not available.*

Figure 1: Probability of Achieving Systolic Blood Pressure Less Than 140 mmHg at Week 8 - image 01

Figure 1: Probability of Achieving Systolic Blood Pressure Less Than 140 mmHg at Week 8 - image 01

This appears to be a graph showing blood pressure readings (SBP - systolic blood pressure) below 140 mmHg, recorded before and after treatment with hydrochlorothiazide 25 mg. The graph also shows a baseline SBP range from 100 to 180 mmHg.*

Figure 2: Probability of Achieving Diastolic Blood Pressure Less Than 90 mmHg at Week 8 - image 02

Figure 2: Probability of Achieving Diastolic Blood Pressure Less Than 90 mmHg at Week 8 - image 02

Figure 3: Probability of Achieving Systolic Blood Pressure Less Than 130 mmHg at Week 8 - image 03

Figure 3: Probability of Achieving Systolic Blood Pressure Less Than 130 mmHg at Week 8 - image 03

Figure 4: Probability of Achieving Diastolic Blood Pressure Less Than 80 mmHg at Week 8 - image 04

Figure 4: Probability of Achieving Diastolic Blood Pressure Less Than 80 mmHg at Week 8 - image 04

This text appears to be a list of medication dosages and medical measurements, including blood pressure and medication names. It is not clear what the context of the list is or what it is intended to be used for, but it may be related to a study or clinical trial.*

Valsartan Structural Formula - image 05

Valsartan Structural Formula - image 05

Hydrochlorothiazide Structural Formula - image 06

Hydrochlorothiazide Structural Formula - image 06

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.